EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹7,896 Cr | ₹6,658 Cr | ₹5,986 Cr | ₹5,855 Cr | ₹6,056 Cr |
What is the latest Revenue of EMCURE PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹7,896 Cr |
| Mar2024 | ₹6,658 Cr |
| Mar2023 | ₹5,986 Cr |
| Mar2022 | ₹5,855 Cr |
| Mar2021 | ₹6,056 Cr |
How is Revenue of EMCURE PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,896 Cr | 18.59 | |
| Mar2024 | ₹6,658 Cr | 11.23 | |
| Mar2023 | ₹5,986 Cr | 2.23 | |
| Mar2022 | ₹5,855 Cr | -3.32 | |
| Mar2021 | ₹6,056 Cr | - | |
Compare Revenue of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹33,653.7 Cr | 4.1% | 2.4% | 28.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,820.0 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 4.1% |
2.4% |
28.6% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses